Eligible Companies for Exchange

A2 Bio is the developer of a cell therapy aimed at curing cancer through precise tumor targeting. The company creates engineered tumor cells that focus on the genetic material deficiencies in tumors, selectively destroying tumor cells while sparing normal ones. This innovative approach allows physicians to transform the treatment of solid tumors.

Aardvark Therapeutics is focused on developing small molecule therapeutics aimed at treating obesity and rare genetic metabolic disorders. Their innovative therapeutics provide a pioneering oral formulation that precisely disrupts hunger signaling while maintaining energy balance, without affecting nutrient absorption. This approach equips healthcare providers with a safe and efficacious treatment option for diseases associated with obesity.

Abpro is a biotechnology firm focused on treating and curing diseases in patients. Utilizing synthetic biology and immunology, the company produces medications against new and challenging targets. This allows biotech and pharmaceutical companies to generate a plethora of therapeutic antibodies against targets typically hard to tackle.

Accutar Biotech is a developer of bio-pharmaceutical technology aimed at speeding up drug discovery. The company employs computational drug design coupled with wet-lab validation, providing tools for side-chain flexible mode ligand docking, virtual screening, and prediction of drug ADME properties. This approach allows researchers to significantly cut down the time and expense typically associated with traditional drug discovery processes.

AcuityMD develops a software platform for medical technology, aimed at enhancing the design and marketing of medical devices. The platform integrates strategic insights and market data into a collaborative tool that can be utilized across different departments, allowing medical companies to foster stronger connections with the physicians they support.

ADARx Pharmaceuticals is a clinical-stage biotechnology company focused on transforming scientific discoveries into life-saving treatments. The company utilizes a proprietary ribonucleic acid (RNA) targeting platform that includes oligonucleotides for inhibition, degradation, and editing, along with innovative oligonucleotide delivery technologies. ADARx Pharmaceuticals is developing an expanding pipeline of RNA-targeting therapeutics aimed at treating a variety of diseases, such as genetic, cardiometabolic, complement-mediated, and central nervous system disorders. This approach enables patients to swiftly treat previously incurable diseases caused by genetic mutations.

AKASA has developed a smart automation technology aimed at enhancing the healthcare revenue cycle. The company's technology provides automation services specifically intended for healthcare revenue cycle management. It examines historical data, enabling the creation of new flows to eradicate manual work and propels efficiency and performance improvements for healthcare institutions. This allows AKASA's clients to address issues arising from financial failures.

Alamar Biosciences has developed a cutting-edge precision proteomics platform aimed at protein analysis and cancer detection. This platform specializes in innovative antibody technologies crucial for diagnosing diseases such as cancer, and it supports the discovery of new biomarkers for early disease detection and prevention. By doing so, Alamar Biosciences enables healthcare providers to identify and potentially treat patients at an early stage, offering hope for early intervention in common diseases.

Aledade operates a health technology platform designed for quick access to integrated data across the care continuum. Aledade's network includes independent primary care, providing data, personal coaching, user-friendly workflows, health policy expertise, strong payer relationships, and integrated services. This framework enables primary care organizations to succeed financially by maintaining patient health, offering comprehensive insights to pinpoint high-priority actions such as risk suggestions, preventive care opportunities, and recent hospital events. This empowers physicians to deliver personalized, on-the-ground care while reducing overall costs.

AliveCor has developed a mobile electrocardiogram device with the purpose of enhancing stroke prevention through early detection of atrial fibrillation. The device allows patients to track their heart health via their smartphones and offers physicians an additional tool for assessing heart health. This innovative tool enables doctors to instantly analyze and detect atrial fibrillation and normal sinus rhythm in an ECG.

Alloy Therapeutics has developed a drug discovery platform designed to support and expedite antibody discovery projects. The company's innovative technology includes humanized transgenic antibody discovery, which offers wide, non-exclusive access to drug discovery tools. This empowers scientists to carry out their antibody projects without any difficulty.

Alma is a healthcare platform designed to assist providers in addressing the demand for mental health care. The platform enables users to search and filter healthcare consultants and equips practitioners with tools such as billing, scheduling, and video chat for patient treatment. This allows healthcare professionals to improve efficiency by taking advantage of a collaborative community.

Alterome Therapeutics specializes in precision oncology treatments aimed at targeting oncogenic drivers. The company's approach leverages structure-guided drug discovery and sophisticated computational chemistry to create alteration-specific small molecule therapies. This enables the healthcare industry to address cancer targets with novel, selective treatments that enhance patient outcomes and increase survival rates.

Alto Pharmacy is the creator of a digital pharmacy platform that strives to deliver an effective pharmacy experience right to your doorstep. This tool merges expert pharmacist care with specially designed technology to provide a more affordable and convenient experience for individuals requiring medication. It offers medication management and scheduled delivery via a mobile application or web portal, empowering businesses to offer superior healthcare services to their patients.

Arbor Biotechnologies develops genomic tools aimed at enhancing human health and promoting sustainability. The company's technology leverages AI and machine learning to compile genomic sequence data, optimizing future cycles of treatments for genetic diseases previously deemed incurable. This enables drug developers to perform whole-gene replacements and accurately correct mutations, facilitating treatment for all patients with genetic disorders.

Areteia Therapeutics developed an oral medication designed to assist patients suffering from eosinophilic asthma. The innovative drug from this company works by inhibiting the maturation of eosinophils before they can cause damage to the airways. This could potentially provide a manageable treatment option for millions of patients grappling with this severe type of asthma. With Areteia Therapeutics' first potential oral drug for eosinophilic asthma, patients can regain better control of their disease and their lives.

ArsenalBio is a pioneering cell therapy company that aims to innovate, develop, and commercialize potential curative immune cell therapies. The company leverages a comprehensive research and development platform that helps create multifunctional T-cell treatments. This is made possible through the strategic insertion of large synthetic DNA sequences. ArsenalBio thus provides clinicians with the most advanced autologous T-cell therapies to combat cancer.

Asimov, a developer of mammalian cell engineering software, aims to expedite the creation and production of gene therapies and biologics. The firm's platform unifies synthetic biology, machine learning-based design, and biophysical simulations to engineer genetic circuits in biotechnology. This allows healthcare institutions to streamline the design and printing of genetic logic gates, leading to the development of sophisticated therapeutics and manufacturing applications.

Athelas has developed an in-home blood diagnostic device that is designed to monitor the immune system using just a drop of blood. This portable optical unit not only images the sample but also analyzes blood cells and generates diagnostic reports. This allows patients to monitor their immunity levels from home and aids doctors in early identification of leukemia, infections, and inflammatory diseases.

Attralus is engaged in creating immunotherapies and an imaging diagnostic platform aimed at treating multiple systemic amyloid diseases. The company's focus is on developing treatments to eliminate amyloid fibrils in patients suffering from systemic amyloid conditions such as light chain, transthyretin, and LECT2 amyloidosis. This enables the healthcare sector to provide more effective treatments for amyloidosis patients.

Axtria operates a cloud and data analytics platform designed to integrate industry expertise, analytics, and technology, offering services that empower the life sciences sector to make informed, data-driven decisions. Axtria's platform facilitates the digital transformation of the entire product commercialization process, enhancing sales growth and improving healthcare outcomes for patients. This enables healthcare enterprises to transition seamlessly from data to insights to action, ensuring they maximize returns on their sales and marketing investments.

Be Biopharma is pioneering B cell medicines designed for applications extending beyond mere cytotoxicity. The company's therapies tackle significant challenges in cell and gene treatments, offering solutions that are durable, reprogrammable, and administrable without harmful conditioning. This innovation empowers healthcare professionals to address diseases such as cancer, autoimmune disorders, and enzyme deficiencies effectively.

Bellabeat is a manufacturer of wellness tracking devices designed to help women monitor and enhance their health. Bellabeat's product offers monitoring of sleep, activity, and reproductive health throughout various life stages, allowing users to handle stress, enrich their lives, and prevent irreversible consequences.

BetterUp has developed an online coaching platform that is designed to enhance the professional performance of employed individuals by advancing their skills. The platform offers weekly virtual sessions with experts for personalized development guidance and delivers actionable insights. This enables employees to enhance their leadership abilities, mindset, and creativity.

BillionToOne is a molecular diagnostics company that aims to create prenatal and oncology assays with unparalleled sensitivity and precision. It provides an ultra-sensitive comprehensive genomic profiling assay that identifies more actionable mutations for selecting treatments. BillionToOne also offers a pan-cancer tumor-naive oncology test, which accurately measures tumor burden from a blood sample to monitor therapy response. Their prenatal tests offer more than simple aneuploidy detection, identifying single-gene disorders like sickle-cell disease, beta-thalassemia, spinal muscular atrophy, and cystic fibrosis through a straightforward blood test.

BioIntellisense has developed a clinical device for continuous health monitoring, predictive analytics, and algorithmic insights. Their device provides medical-grade monitoring through sensor-enabled wearable technology that performs advanced analytics for early detection of skin temperature, heart rate, respiratory rate, fall detection, coughing, sneezing, and vomiting frequency. This real-time data is channeled to their platform, enabling hospitals to assess vital signs, physiological biometrics, and symptomatic events in patients.

Blink Health provides a digital and prescription medicine platform designed to offer medications online at competitive prices. Through this platform, users can purchase prescription drugs online and either pick them up at their local pharmacy or have them delivered to their doorstep. This service enables customers to save both money and time while purchasing their medications.

Bluejay Therapeutics develops therapeutic medicines aimed at providing curative treatments for serious viral and liver diseases. The company's approach targets the reduction of viral surface antigen monoclonal antibodies to restore adaptive immunity, with an initial focus on chronic hepatitis B (CHB) and chronic hepatitis D (CHD). This enables patients to enhance their immunity and recover from infections.

BostonGene develops biomedical software for advanced patient analysis and personalized therapy. Their platform utilizes artificial intelligence for molecular genetic and immune profiling, decoding cancer patients' molecular profiles, including the immune system and tumor microenvironment. This approach uncovers key disease drivers, identifies novel drug targets, and recommends effective treatments. By providing precise, clinically validated insights, BostonGene enables clinicians to drive precision medicine and advance oncology research.

BrightInsight has developed a digital health platform that streamlines the optimization of regulated medications, devices, and software via integrated data and actionable insight. The platform employs software and services to gather, transmit, and analyze data from FDA-regulated and CE-marked medical devices, combination products, and software as a medical device. It adheres to security, privacy, and regulatory requirements. This enables biopharma and med-tech firms to expedite their market entry, decrease implementation and scaling costs across products, and expand into global markets.

Brightline operates a healthcare platform designed to revolutionize behavioral health care for kids, adolescents, and their families. Brightline's platform incorporates resources and education, behavioral therapy, interactive treatment activities, and coaching to foster skill development and provide assistance during challenging situations. It also offers speech therapy for a variety of behavioral and developmental health requirements. This enables parents to schedule and monitor their child's progress through teletherapy.

Brightside Health operates as a healthcare company dedicated to reducing anxiety and depression. Their platform emphasizes depression evaluation, treatment, and monitoring using clinically validated assessments and insights. It offers lifestyle tools, resources, medication, therapy referrals, and progress tracking, allowing patients to access quality depression care. This empowers them to maintain healthy, balanced, and productive lives.

Cadence Solutions is a digital healthcare company that aids physicians in enhancing the treatment of common diseases. The firm is an expert in virtual patient monitoring and management of chronic conditions. It supports patients suffering from hypertension, chronic obstructive pulmonary disease, and heart failure. Cadence Solutions provides patients with an avenue to receive care outside the hospital setting.

Calm, a developer of sleep, meditation, and relaxation applications, is designed to alleviate anxiety and provide a serene life for its users. The company's application offers unique audio content, stories, and programs that address critical mental health issues prevalent in today's society, including anxiety, stress, and insomnia. This enables users to combat stress, lead joyful lives, and maintain better health.

Candid Therapeutics, a pioneer in biotechnology research, focuses on developing novel, easy-to-administer therapies for autoimmune diseases. The company specializes in advanced T-cell engager antibodies that precisely redirect T-cells to selectively eliminate autoreactive B-cells. This targeted approach enables patients with autoimmune diseases to achieve transformative efficacy and improved therapeutic outcomes.

Capital Rx has developed a corporate pharmacy platform designed to revolutionize the pricing of prescription drugs and the service provided to patients. This platform links all facets of the pharmacy ecosystem to enhance the healthcare infrastructure, thereby improving drug price transparency and patient results. This allows healthcare providers to augment patient involvement and healthcare effectiveness to reach specific clinical care standards.

Capstan Therapeutics aims to enhance the potential of in vivo RNA-based therapies by utilizing its proprietary targeted delivery systems. The company employs targeted lipid nanoparticles to facilitate off-the-shelf immunotherapies, ensuring precise control over the dosage and activity of engineered cells. This approach allows researchers to develop groundbreaking products for treating oncology, fibrosis, and inflammation-related diseases.

Capsule Pharmacy offers digital pharmacy services designed to streamline the delivery of prescription medication. Their platform accepts prescriptions directly from doctors and lets patients transfer their refills from their previous pharmacy to Capsule Pharmacy. This enables patients to receive their medication on the same day.

Carbon Health operates mobile-based healthcare networks and clinics that are designed to provide convenient and accessible healthcare services. The company offers omnichannel care from trusted healthcare providers through various touchpoints, such as clinics, pop-up sites, video consultations, and mobile applications. This allows patients to access technology-driven healthcare services from any location.

Cardurion Pharma, a developer of cardiovascular therapeutics, is dedicated to addressing cardiovascular diseases. The company's advanced and innovative therapeutics provide new treatment mechanisms for heart diseases that contribute to morbidity and mortality. This enables healthcare professionals to effectively prevent arrhythmia disorders and heart failures.

CareBridge Health is a value-based healthcare company that specializes in supporting states and health plans in providing care to individuals receiving home and community-based services. The company is dedicated to offering 24/7 clinical support to patients, their families, and paid caregivers. It ensures that members are equipped with the necessary services, equipment, and support to live independently at home. CareBridge Health allows family members and caregivers to stay connected with a care team around the clock.

Carmot Therapeutics Inc, a clinical-stage biotech firm, is committed to creating transformative treatments for individuals suffering from metabolic disorders such as obesity and diabetes. The company has three clinical-stage product candidates in its pipeline: CT-388, a once-weekly injectable dual GLP-1/GIP receptor agonist for combating obesity and type 2 diabetes (T2D); CT-996, a once-daily oral small molecule GLP-1 receptor agonist also aimed at treating obesity and T2D; and CT-868, a once-daily injectable dual GLP-

Carrum Health operates an online healthcare platform designed to assist employers in offering top-tier healthcare benefits to their workforce. This platform connects forward-thinking, self-insured employers with regional healthcare providers using a comprehensive bundled payment system. This model helps patients lower their healthcare expenses, often resulting in little to no out-of-pocket costs.

Casana develops in-home health monitoring technologies designed to empower practitioners in managing patients' cardiac health from home. Casana's device passively collects health parameters and analyzes them within context, aiming to deliver unique insights into health and trends over time. This enables caregivers to access reliable and consistent vital signs information, ultimately improving the lives of individuals.

Cedar, a healthcare financial engagement platform developer, is designed to oversee the patient payment ecosystem. The company's platform employs contemporary intelligence to enhance billing operations, ensuring a customized patient billing experience. It allows hospitals, health systems, and medical groups to merge billing data from various caregivers while providing patients with comprehensible invoices. The platform also offers personalized click-to-pay options.

Cellanome has developed a distinctive multi-omics platform aimed at analyzing biology with unmatched detail and scale. The company's platform is adept in genome sequencing, microfluidics, and integrated sensors, along with expertise in molecular biology and biochemistry. This empowers scientists to create innovative solutions for intricate biological challenges.

Cellares is a dedicated Integrated Development and Manufacturing Organization, striving to expedite the availability of life-saving cell therapies for patients. This company is at the forefront of developing and implementing integrated cell therapy manufacturing technologies. This not only accelerates the pace of drug development but also facilitates manufacturing scale-out, thereby fulfilling global patient demand. Cellares works in collaboration with academic institutions, biotech firms, and pharmaceutical companies, facilitating faster drug development.

Cellarity is a developer of a biomedical platform aimed at digitizing molecular information within cells to understand their behavior in both health and disease. The company's platform leverages single-cell technologies and machine learning to digitize and quantify cellular behaviors, uncover the network dynamics that drive these behaviors, and develop medicines capable of directing them. This approach enables other companies to enhance the success rate and speed of drug discovery.